PMND1: John Lieske, M.D.

from Answers from the Lab · host Mayo Clinic Laboratories

(00:31) Could you tell us a bit about yourself and your background?(01:11) Could you describe these new tests and when it would be appropriate to use each of them in the clinic?(03:16) Could you provide a little background on why MCL is making changes to the PLA2R test?(04:34) Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will these new tests help physicians implement these new guidelines in their practices?

Episode metadata supplied by the publisher feed · Published Aug 16, 2022

Embed this episode

Attribution link and audio player

What this episode covers

John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides cost-effective testing to determine the antigen that's causing the kidney disease.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

PMND1: John Lieske, M.D.

0:00 8:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Answers from the Lab?

This episode is 8 minutes long.

When was this Answers from the Lab episode published?

This episode was published on August 16, 2022.

Can I download this Answers from the Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!